Home-based mindfulness and health coaching for older patients with multiple myeloma
Remote Monitoring With Health-Coaching for Lifestyle Changes in Older Patients With Multiple Myeloma
NA · Mayo Clinic · NCT06145581
This study is testing a home-based program that combines mindfulness exercises and health coaching to see if it can help older patients with multiple myeloma feel less tired and improve their quality of life.
Quick facts
| Phase | NA |
|---|---|
| Study type | Interventional |
| Enrollment | 25 (estimated) |
| Ages | 65 Years and up |
| Sex | All |
| Sponsor | Mayo Clinic (other) |
| Locations | 1 site (Rochester, Minnesota) |
| Trial ID | NCT06145581 on ClinicalTrials.gov |
What this trial studies
This clinical trial evaluates a home-based mindfulness physical activity program combined with remote monitoring and structured telephone health coaching aimed at reducing fatigue and enhancing quality of life in older patients with multiple myeloma. Participants will engage in daily physical activities such as flexibility exercises and slow walking, monitored remotely, while receiving weekly health coaching calls over a 12-week period. The effectiveness of this intervention will be assessed through patient-reported fatigue and quality of life questionnaires, as well as physical activity levels measured by a wrist monitor.
Who should consider this trial
Good fit: Ideal candidates are older adults aged 65 and above who have been diagnosed with multiple myeloma and are currently undergoing maintenance treatment.
Not a fit: Patients who do not meet the inclusion criteria, such as those with less than moderate fatigue or without a Wi-Fi connection, may not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could significantly improve the quality of life and reduce fatigue in older patients suffering from multiple myeloma.
How similar studies have performed: Previous studies have indicated that mindfulness and physical activity can positively impact fatigue and quality of life in older cancer patients, suggesting potential success for this approach.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Diagnosed with MM and has received treatment with \>= 1 prior lines of treatment, and currently on maintenance treatment with a proteasome inhibitor and/or immunomodulatory agent, and/or anti-C38 antibody * The ability to read and respond to questions in English * Age ≥ 65 years * Moderate or higher fatigue ( \> 4) on a scale of 0-10 based on fatigue rating to question: - Rate your average fatigue over the last week, where 0 is no fatigue and 10 is extreme fatigue * Have wi-fi connection, as the program requires wi-fi to operate Exclusion Criteria: * Does not meet listed inclusion criteria
Where this trial is running
Rochester, Minnesota
- Mayo Clinic in Rochester — Rochester, Minnesota, United States (RECRUITING)
Study contacts
- Principal investigator: Nadine H. Abdallah, MD — Mayo Clinic in Rochester
- Study coordinator: Clinical Trials Referral Office
- Email: mayocliniccancerstudies@mayo.edu
- Phone: 855-776-0015
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Multiple Myeloma